<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>T cryptantigen can be exposed on the red cell membrane as a result of removal of terminal <z:chebi fb="0" ids="24400">glycosides</z:chebi>, either by <z:mp ids='MP_0001794'>bacterial</z:mp> enzymes or by incomplete synthesis of the cell membrane due to <z:hpo ids='HP_0001428'>somatic mutation</z:hpo>, usually caused by a <z:hpo ids='HP_0002664'>neoplasm</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>T-activated erythrocytes have been observed in different pathologies, but they have not been seen associated with other abnormalities of red blood cell proteins described in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> or <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mpath ids='MPATH_336'>leukaemias</z:mpath> </plain></SENT>
<SENT sid="2" pm="."><plain>A patient with initial diagnosis of refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> that evolved into <z:e sem="disease" ids="C0023440" disease_type="Neoplastic Process" abbrv="">erythroleukaemia</z:e> showed prolonged T-activation, a depressed A blood-group antigen and an increase of foetal <z:chebi fb="34" ids="35143">haemoglobin</z:chebi>, simultaneously </plain></SENT>
<SENT sid="3" pm="."><plain>The evolutive pattern of T-activation suggests more an <z:mp ids='MP_0000245'>abnormal erythropoiesis</z:mp> than an enzymatic effect and a certain relationship with the haemolytic syndrome </plain></SENT>
</text></document>